Brief

"On 26/10/2023, the South African Health Products Regulatory Authority (SAHPRA) issued an update regarding Update on COVID-19 vaccines. SAHPRA currently has four COVID-19 vaccines under review and has registered a total of eight mRNA and non-mRNA vaccines, including COMIRNATY, Pfizer COVID-19 Adult RTU, and Covovax COVID-19 vaccine."

This content is restricted.

Highlights content goes here...

This content is restricted.

South African Health Products Regulatory Authority (SAHPRA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies